Bharat Biotech
Hyderabad · Founded 1996
About Bharat Biotech
Bharat Biotech International Limited, a biotechnology company, engages in the research, development, and manufacture of vaccines and biotherapeutics. Its products include Revac-B+, a recombinant hepatitis-B vaccine; TYPBAR, a vi polysaccharide typhoid vaccine; BIOPOLIO, a poliomyelitis vaccine; INDIRAB, a rabies vaccine; Revac-Bmcf, a thiomersal free recombinant hepatitis-B vaccine; TEVAC, a tetanus vaccine; Scorgen, a scorpion venom anti-serum; and BioHib, a haemophilus influenza type b vaccine
Company Facts
- Founded: 1996
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $1K – $10K
- Total funding: $14.1M
- Last round: Grant (Jun 2020)
- Website: bharatbiotech.com
- Phone: +914023480567
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/bharat-biotech-46312 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.